Skip to main content

01-11-2017 | Healthcare systems | Article

Racial/Ethnic Disparities in Diabetes Quality of Care: the Role of Healthcare Access and Socioeconomic Status

Journal: Journal of Racial and Ethnic Health Disparities

Authors: Juan R. Canedo, Stephania T. Miller, David Schlundt, Mary K. Fadden, Maureen Sanderson

Publisher: Springer International Publishing



Blacks, Hispanics, and Asians are disproportionately affected by diabetes. We assessed the state of racial/ethnic disparities in diabetes quality of care in the USA.


We analyzed cross-sectional data of adults diagnosed with Type 2 diabetes in the nationally representative 2013 Medical Expenditure Panel Survey. Differences in adherence to five diabetes quality of care recommendations (HbA1c twice yearly, yearly foot exam, dilated eye exam, blood cholesterol test, and flu vaccination) were examined by race/ethnicity while controlling for three social determinants of health (health insurance status, poverty, and education) and other demographic variables.


Among adults with diabetes in the USA, 74.9% received two or more HbA1c tests, 69.0% had a foot exam, 64.9% had an eye exam, 85.4% had a cholesterol test, and 65.1% received flu vaccination in 2013. Compared to Whites, all were lower for Hispanics; HbA1c tests, eye exam, and flu vaccination were lower for Blacks; HbA1c tests, foot exam, and eye exam were lower for Asians. In adjusted models, the only remaining disparities in quality of care indicators were HbA1c tests for Hispanics (AOR 0.67, CI = 0.47–0.97), Blacks (AOR 0.59, CI = 0.40–0.88), and Asians (AOR 0.47, CI = 0.42–0.99); foot exams for Hispanics (AOR 0.65, CI = 0.47–0.90); and flu vaccination for Blacks (AOR 0.68, CI = 0.49–0.93).


Lack of insurance coverage and education explained some of the racial/ethnic disparities observed in diabetes quality of care. Improving quality of diabetes care could help reduce rates of diabetes complications, healthcare costs, and mortality.
Center for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014 [Internet]. GA: U.S. Department of Health and Human Services; 2014 p. 1–12. Available from: https://​www.​cdc.​gov/​diabetes/​pubs/​statsreport14/​national-diabetes-report-web.​pdf
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88. CrossRefPubMed
Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. US Renal Data System 2011 annual data report. Am J Kidney Dis. 2012;59:A7. CrossRefPubMed
Zhang X, Saaddine JB, Chou C-F, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA J Am Med Assoc. 2010;304:649–56. CrossRef
Chow EA, Foster H, Gonzalez V, McIver L. The disparate impact of diabetes on racial/ethnic minority populations. Clin Diabetes. 2012;30:130–3. CrossRef
Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol CJASN. 2013;8:1685–93. CrossRefPubMed
Nwanyanwu KH, Newman-Casey P-A, Gardner TW, Lim JI. Beyond HbA1c: environmental risk factors for diabetic retinopathy. J. Clin. Exp. Ophthalmol. [Internet]. 2015 [cited 2016 Sep 19];6. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4785841/​
Clark ML, Utz SW. Social determinants of type 2 diabetes and health in the United States. World J Diabetes. 2014;5:296–304. CrossRefPubMedPubMedCentral
Zheng H, George LK. Rising U.S. income inequality and the changing gradient of socioeconomic status on physical functioning and activity limitations, 1984–2007. Soc Sci Med. 2012;75:2170–82. CrossRefPubMed
Montez JK, Zajacova A. Explaining the widening education gap in mortality among U.S. white women. J Health Soc Behav. 2013;54:166–82. CrossRefPubMedPubMedCentral
Pampel FC, Krueger PM, Denney JT. Socioeconomic disparities in health behaviors. Annu Rev Sociol. 2010;36:349–70. CrossRefPubMedPubMedCentral
O’Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E, et al. Diabetes performance measures: current status and future directions. Diabetes Care. 2011;34:1651–9. CrossRefPubMedPubMedCentral
Cooperberg MR, Birkmeyer JD, Litwin MS. Defining high quality health care. Urol Oncol. 2009;27:411–6. CrossRefPubMed
Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514–23. CrossRefPubMed
American Diabetes Association. Standards of medical care in diabetes. 2016;39:S1–2.
American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–66. CrossRef
Laiteerapong N, Fairchild PC, Chou C-H, Chin MH, Huang ES. Revisiting disparities in quality of care among US adults with diabetes in the era of individualized care, NHANES 2007-2010. Med Care. 2015;53:25–31. CrossRefPubMedPubMedCentral
Richard P, Alexandre PK, Lara A, Akamigbo AB. Racial and ethnic disparities in the quality of diabetes care in a nationally representative sample. Prev. Chronic. Dis. [Internet]. 2011;8. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC3221581/​
Pu J, Chewning B. Racial difference in diabetes preventive care. Res Soc Adm Pharm RSAP. 2013;9:790–6. CrossRef
Hu R, Shi L, Rane S, Zhu J, Chen C-C. Insurance, racial/ethnic, SES-related disparities in quality of care among US adults with diabetes. J Immigr Minor Health Cent Minor Public Health. 2014;16:565–75. CrossRef
Walker R, Strom W, Egede L. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci. 2016;35:366–73. CrossRef
MEPS HC-163 2013 Full Year Consolidated Data File [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2015 p. 1–185. Available from: https://​meps.​ahrq.​gov/​data_​stats/​download_​data/​pufs/​h163/​h163doc.​pdf
IBM SPSS Statistics Version 24.0. Armonk, NY: IBM Corporation; 2016.
Healthy People 2020: Diabetes [Internet]. Office of Disease Prevention and Health Promotion; 2016 [cited 2016 Oct 5]. Available from: https://​www.​healthypeople.​gov/​2020/​topics-objectives/​topic/​diabetes/​objectives

Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video